Galen buys licence for generic contraception
Northern pharmaceutical company Galen Holdings has said it bought an exclusive licence for a generic version of Galen's Ovcon 35 oral contraceptive from Barr Pharmaceuticals, for €19m
(€15.74m).
Try from €1.25 / week
SUBSCRIBENorthern pharmaceutical company Galen Holdings has said it bought an exclusive licence for a generic version of Galen's Ovcon 35 oral contraceptive from Barr Pharmaceuticals, for €19m
(€15.74m).
CONNECT WITH US TODAY
Be the first to know the latest news and updates
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.
Push Notifications
By clicking on sign up you will be the first to know about a selection of business content on this browser. Please note if you are unable to sign up via your mobile web browser, download and sign up for mobile push notifications via our FREE news app.
Sign UpYou have accepted push notifications for this content. If you would like to manage your push notification preferences, you can do so here.
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.
Tuesday, September 30, 2025 - 11:00 AM
Tuesday, September 30, 2025 - 11:00 AM
Tuesday, September 30, 2025 - 9:00 AM
© Examiner Echo Group Limited